mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.6 |
mRNA |
dinaciclib |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.6 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
spautin-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
blebbistatin |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.6 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
MLN2480 |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.6 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
KPT185 |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |